Seribelli Amanda Ap, Frazão Miliane R, Medeiros Marta I Cazentini, Falcão Juliana P
Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Instituto Adolfo Lutz de Ribeirão Preto, São Paulo, Brazil.
J Med Microbiol. 2016 Jul;65(7):666-677. doi: 10.1099/jmm.0.000290. Epub 2016 Jun 6.
Shigella sonnei is an important causative agent of bacillary dysentery worldwide that has recently emerged in developing countries. However, there are few studies that have characterized strains ofS. sonnei isolated in Brazil. The aims of this study were to assess the presence of 12 virulence genes, the antimicrobial resistance profile against 16 drugs and the genotypic diversity of strains of S. sonnei isolated in this country. Seventy-two strains of S. sonnei isolated from human diarrhoeic faeces in São Paulo State, Brazil from 1983-2014 were studied. All of the strains contained the ipaH, iuc and sigA genes. The ipaBCD gene was detected in 19 % of the strains, the ial and virF genes in 18 % and the sen gene in 10 % of the strains. The set1A, set1B, pic,sepA and sat genes were not detected. A total of 42 (58.3 %) strains were resistant to trimethoprim-sulfamethoxazole. Thirty (41.6 %) strains were resistant to tetracycline. The S. sonnei strains were grouped in two clusters called A and B by PFGE and ERIC-PCR, and the majority of the strains comprised in each cluster presented ≥80 % similarity. In conclusion, the pathogenic potential of the strains studied was highlighted by the presence of important virulence genes. The high rates of resistance to trimethoprim-sulfamethoxazole and tetracycline are alarming once those drugs can be used in the treatment of shigellosis. The PFGE and ERIC-PCR results suggest that there are two prevalent subtypes in the studied strains of S. sonnei that differed little over 31 years and have been contaminating humans and causing diseases in São Paulo State, Brazil.
宋内志贺菌是全球范围内引起细菌性痢疾的重要病原体,最近在发展中国家出现。然而,关于在巴西分离的宋内志贺菌菌株的特征研究较少。本研究的目的是评估12个毒力基因的存在情况、对16种药物的抗菌耐药谱以及在该国分离的宋内志贺菌菌株的基因型多样性。对1983年至2014年从巴西圣保罗州人类腹泻粪便中分离出的72株宋内志贺菌进行了研究。所有菌株都含有ipaH、iuc和sigA基因。19%的菌株检测到ipaBCD基因,18%的菌株检测到ial和virF基因,10%的菌株检测到sen基因。未检测到set1A、set1B、pic、sepA和sat基因。共有42株(58.3%)菌株对甲氧苄啶-磺胺甲恶唑耐药。30株(41.6%)菌株对四环素耐药。通过脉冲场凝胶电泳(PFGE)和肠杆菌基因间重复共有序列聚合酶链反应(ERIC-PCR)将宋内志贺菌菌株分为A和B两个簇,每个簇中的大多数菌株相似度≥80%。总之,重要毒力基因的存在突出了所研究菌株的致病潜力。鉴于这些药物可用于治疗志贺菌病,对甲氧苄啶-磺胺甲恶唑和四环素的高耐药率令人担忧。PFGE和ERIC-PCR结果表明,在所研究的宋内志贺菌菌株中有两种流行亚型,在31年中变化不大,一直在巴西圣保罗州感染人类并引起疾病。